Search Results - "GALINDO, Maria J"

Sustained Virological Response to Interferon Plus Ribavirin Reduces Non—Liver-Related Mortality in Patients Coinfected With HIV and Hepatitis C Virus by Berenguer, Juan, Rodríguez, Elena, Miralles, Pilar, Von Wichmann, Miguel A., López-Aldeguer, José, Mallolas, Josep, Galindo, María J., Van Den Eynde, Eva, Téllez, María J., Quereda, Carmen, Jou, Antoni, Sanz, José, Barros, Carlos, Santos, Ignacio, Pulido, Federico, Guardiola, Josep M., Ortega, Enrique, Rubio, Rafael, Jusdado, Juan J., Montes, María L., Gaspar, Gabriel, Esteban, Herminia, Bellón, José M., González-García, Juan

“…Background. Sustained virological response (SVR) after therapy with interferon plus ribavirin reduces liver-related complications and mortality in patients…”
Get full text

Weight gain in HIV-infected patients by Rodríguez, Antoni Pla, Lillo, Isabel Serrano, González, Cristina Sánchez, Galindo, María J

“…Since its emergence, HIV has been linked to metabolic alterations with an impact on the distribution of fat and the weight of people living with HIV. While…”
Get full text

Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients by Merchante, Nicolás, Rodríguez-Fernández, Miguel, Figueruela, Blanca, Rodríguez-Arrondo, Francisco, Revollo, Boris, Ibarra, Sofía, Téllez, Francisco, Merino, Esperanza, Montero-Alonso, Marta, Galindo, María J., Rivero-Juárez, Antonio, Santos, Ignacio de Los, Delgado-Fernández, Marcial, García-Deltoro, Miguel, Vera-Méndez, Francisco J., García, María A., Aguirrebengoa, Koldo, Portu, Joseba, Ríos-Villegas, María J., Villalobos, Marina, Alemán-Valls, María R., Mínguez, Carlos, Galera, Carlos, Macías, Juan, Pineda, Juan A.

“…Previous studies have suggested that hepatocellular carcinoma (HCC) has an aggressive presentation and a shorter survival in people with HIV (PWH). This could…”
Get full text

Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients by Merchante, Nicolás, Rodríguez-Arrondo, Francisco, Revollo, Boris, Merino, Esperanza, Ibarra, Sofía, Galindo, María J, Montero, Marta, García-Deltoro, Miguel, Rivero-Juárez, Antonio, Téllez, Francisco, Delgado-Fernández, Marcial, Ríos-Villegas, María J, García, María A, Vera-Méndez, Francisco J, Ojeda-Burgos, Guillermo, López-Ruz, Miguel A, Metola, Luis, Omar, Mohamed, Alemán-Valls, María Remedios, Aguirrebengoa, Koldo, Portu, Joseba, Raffo, Miguel, Macías, Juan, Pineda, Juan A

“…OBJECTIVE:To assess the possible association between the use of direct antiviral agents (DAA) and the risk of hepatocellular carcinoma (HCC) in HIV/hepatitis C…”
Get full text

Down-Regulation of the Longevity-Associated Protein SIRT1 in Peripheral Blood Mononuclear Cells of Treated HIV Patients by Gruevska, Aleksandra, Moragrega, Ángela B, Galindo, María J, Esplugues, Juan V, Blas-García, Ana, Apostolova, Nadezda

“…The activity of sirtuin 1 (SIRT1), a class III histone deacetylase with a critical role in several biological functions, decreases with age and its deficiency…”
Get full text

Risk, Diagnostic and Predictor Factors for Classical Hodgkin Lymphoma in HIV-1-Infected Individuals: Role of Plasma Exosome-Derived miR-20a and miR-21 by Hernández-Walias, Francisco J, Vázquez, Esther, Pacheco, Yolanda, Rodríguez-Fernández, José M, Pérez-Elías, María J, Dronda, Fernando, Casado, José L, Moreno, Ana, Hermida, José M, Quereda, Carmen, Hernando, Asunción, Tejerina-Picado, Francisco, Asensi, Víctor, Galindo, María J, Leal, Manuel, Moreno, Santiago, Vallejo, Alejandro

“…The incidence of classical Hodgkin lymphoma (cHL) in the HIV-1 setting has increased 5-25-fold compared to that observed in the general population. This study…”
Get full text

Efavirenz and the CNS: what we already know and questions that need to be answered by Apostolova, Nadezda, Funes, Haryes A, Blas-Garcia, Ana, Galindo, Maria J, Alvarez, Angeles, Esplugues, Juan V

“…The NNRTI efavirenz has long been one of the most frequently employed antiretroviral drugs in the multidrug regimens used to treat HIV infection, in accordance…”
Get full text

Efavirenz: What is known about the cellular mechanisms responsible for its adverse effects by Apostolova, Nadezda, Blas-Garcia, Ana, Galindo, Maria J., Esplugues, Juan V.

“…The HIV infection remains an important health problem worldwide. However, due to the efficacy of combined antiretroviral therapy (cART), it has ceased to be a…”
Get full text

Cardiovascular toxicity of abacavir: a clinical controversy in need of a pharmacological explanation by Alvarez, Angeles, Orden, Samuel, Andújar, Isabel, Collado-Diaz, Victor, Núñez-Delgado, Sara, Galindo, Maria J, Estrada, Vicente, Apostolova, Nadezda, Esplugues, Juan V

“…: There is a long-lasting controversy surrounding an association between abacavir (ABC) and an increased risk of cardiovascular disease in HIV-positive…”
Get full text

Safety of Switching Nevirapine Twice Daily to Nevirapine Once Daily in Virologically Suppressed Patients by Podzamczer, Daniel, Olmo, Montserrat, Sanz, Jose, Boix, Vicente, Negredo, Eugenia, Knobel, Hernando, Domingo, Pere, Pineda, Juan A, Vilades, Consuelo, Quero, Jose Hernandez, Force, Lluis, Lahoz, Juan Gonzalez, Muñoz, Pepa, Llibre, Josep M, Mariño, Ana, Ortega, Enrique, Dalmau, David, Gatell, Josep M, Antón, Esperanza, Sola, Julio, Galindo, María J, Pedrol, Enric, Sanz, Jesus, Lima, Javier Torre de, Flores, Juan

“…BACKGROUND:The strategy of switching nevirapine (NVP) twice daily to once daily was evaluated. METHODS:Forty-eight-week randomized, open, multicenter trial…”
Get full text

p53 and p53-related mediators PAI-1 and IGFBP-3 are downregulated in peripheral blood mononuclear cells of HIV-patients exposed to non-nucleoside reverse transcriptase inhibitors by Gruevska, Aleksandra, Moragrega, Angela B., Galindo, Maria J., Esplugues, Juan V., Blas-Garcia, Ana, Apostolova, Nadezda

“…The improved effectiveness and safety of the combined antiretroviral therapy (cART) has largely diminished mortality and AIDS-defining morbidity of…”
Get full text

Eradication of hepatitis C virus and non‐liver‐related non–acquired immune deficiency syndrome–related events in human immunodeficiency virus/hepatitis C virus coinfection by Berenguer, Juan, Rodríguez‐Castellano, Elena, Carrero, Ana, Von Wichmann, Miguel A., Montero, Marta, Galindo, María J., Mallolas, Josep, Crespo, Manuel, Téllez, María J., Quereda, Carmen, Sanz, José, Barros, Carlos, Tural, Cristina, Santos, Ignacio, Pulido, Federico, Guardiola, Josep M., Rubio, Rafael, Ortega, Enrique, Montes, María L., Jusdado, Juan J., Gaspar, Gabriel, Esteban, Herminia, Bellón, José M., González‐García, Juan

“…We assessed non‐liver‐related non–acquired immunodeficiency syndrome (AIDS)‐related (NLR‐NAR) events and mortality in a cohort of human immunodeficiency virus…”
Get full text

The experience of inflammatory bowel disease patients with healthcare: A survey with the IEXPAC instrument by Marín-Jiménez, Ignacio, Casellas, Francesc, Cortés, Xavier, García-Sepulcre, Mariana F., Juliá, Berta, Cea-Calvo, Luis, Soto, Nadia, Navarro-Correal, Ester, Saldaña, Roberto, de Toro, Javier, Galindo, María J., Orozco-Beltrán, Domingo

“…To assess inflammatory bowel disease (IBD) patients' experience of chronic illness care and the relationship with demographic and healthcare-related…”
Get full text

Effects of Eradication of HCV on Cardiovascular Risk and Preclinical Atherosclerosis in HIV/HCV-Coinfected Patients by Carrero, Ana, Berenguer, Juan, Hontañón, Víctor, Navarro, Jordi, Hernández-Quero, José, Galindo, María J., Quereda, Carmen, Santos, Ignacio, Téllez, María J., Ortega, Enrique, Sanz, José, Medrano, Luz M., Pérez-Latorre, Leire, Bellón, José M., Resino, Salvador, Bermejo, Javier, González-García, Juan

“…BACKGROUND:To assess the effects of eradication of hepatitis C virus (HCV) on cardiovascular risk (CVR) and preclinical atherosclerosis in HIV/HCV-coinfected…”
Get full text

HIV/hepatitis C virus-coinfected patients who achieved sustained virological response are still at risk of developing hepatocellular carcinoma by MERCHANTE, Nicolás, MERINO, Esperanza, AGUIRREBENGOA, Koldo, ROMERO-PALACIOS, Alberto, MARTINEZ, Eduardo, PINEDA, Juan A, RODRIGUEZ-ARRONDO, Francisco, TURAL, Cristina, MUNOZ, Josefa, DELGADO-FERNANDEZ, Marcial, JOVER, Francisco, GALINDO, Maria J, RIVERO, Antonio, LOPEZ-ALDEGUER, José

“…To describe the frequency and the characteristics of hepatocellular carcinoma (HCC) cases that appeared in HIV/hepatitis C virus (HCV)-coinfected patients with…”
Get full text

Real-life experience with sorafenib for the treatment of hepatocellular carcinoma in HIV-infected patients by Merchante, Nicolás, Ibarra, Sofía, Revollo, Boris, Rodríguez-Arrondo, Francisco, Merino, Esperanza, Delgado-Fernández, Marcial, Montero-Alonso, Marta, Téllez, Francisco, Galindo, Maria J, Rivero-Juárez, Antonio, García, Maria A, Mínguez, Carlos, Romero-Palacios, Alberto, Garcia-Deltoro, Miguel, Pineda, Juan A

“…OBJECTIVE:To report the real-life results of sorafenib use in a cohort of HIV-infected patients with hepatocellular carcinoma (HCC). METHODS:The GEHEP-002…”
Get full text

Factors associated with the number of drugs in darunavir/cobicistat regimens by Martinez, Esteban, Negredo, Eugenia, Knobel, Hernando, Ocampo, Antonio, Sanz, Jose, Garcia-Fraile, Lucio, Martin-Carbonero, Luz, Lozano, Fernando, Gonzalez-Domenech, Carmen M, Gutierrez, Mar, Montero, Marta, Boix, Vicente, Payeras, Antoni, Torralba, Miguel, Gonzalez-Cordon, Ana, Moreno, Ana, Alejos, Belen, Perez-Elias, Maria J

“…Abstract Background Darunavir/cobicistat can be used as mono, dual, triple or more than triple therapy. Objectives To assess factors associated with the number…”
Get full text

Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patients by Merchante, Nicolás, Figueruela, Blanca, Rodríguez-Fernández, Miguel, Rodríguez-Arrondo, Francisco, Revollo, Boris, Ibarra, Sofía, Galindo, María J, Merino, Esperanza, Montero, Marta, Téllez, Francisco, García-Deltoro, Miguel, Rivero-Juárez, Antonio, Delgado-Fernández, Marcial, Ríos-Villegas, María J, Aguirrebengoa, Koldo, García, María A, Portu, Joseba, Vera-Méndez, Francisco J, Villalobos, Marina, Mínguez, Carlos, De Los Santos, Ignacio, López-Ruz, Miguel A, Omar, Mohamed, Galera, Carlos, Macias, Juan, Pineda, Juan A

“…OBJECTIVE:To assess the performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma (HCC) in HIV-infected patients. METHODS:The…”
Get full text

The Experience With Health Care of Patients With Inflammatory Arthritis: A Cross-sectional Survey Using the Instrument to Evaluate the Experience of Patients With Chronic Diseases by de Toro, Javier, Cea-Calvo, Luis, García-Vivar, María L., Pantoja, Lucía, Lerín-Lozano, Cristina, García-Díaz, Silvia, Galindo, María J., Marín-Jiménez, Ignacio, Fernández, Sabela, Mestre, Yvonne, Orozco-Beltrán, Domingo

“…BACKGROUNDPatientsʼ experience with health care is becoming a key component for the provision of a patient-centered health care model. The aim of this study…”
Get full text

Healthcare Experience and their Relationship with Demographic, Disease and Healthcare-Related Variables: A Cross-Sectional Survey of Patients with Chronic Diseases Using the IEXPAC Scale by Orozco-Beltrán, Domingo, de Toro, Javier, Galindo, María J., Marín-Jiménez, Ignacio, Casellas, Francesc, Fuster-RuizdeApodaca, María J., García-Vivar, María L., Hormigo-Pozo, Antonio, Guilabert, Mercedes, Sánchez-Vega, Nuria, Fernández, Gonzalo, Cea-Calvo, Luis

“…Background Patient experience is acknowledged as a principal aspect of quality healthcare delivery, and it has implications with regard to outcomes. Objectives…”
Get full text